99 related articles for article (PubMed ID: 10470218)
1. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
[TBL] [Abstract][Full Text] [Related]
2. Improvement of differential diagnosis of lung cancer by use of multiple protein tumor marker combinations.
Trulson I; Klawonn F; von Pawel J; Holdenrieder S
Tumour Biol; 2024; 46(s1):S81-S98. PubMed ID: 38277317
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission.
Muley T; Herth FJ; Heussel CP; Kriegsmann M; Thomas M; Meister M; Schneider MA; Wehnl B; Mang A; Holdenrieder S
Tumour Biol; 2024; 46(s1):S219-S232. PubMed ID: 37840518
[TBL] [Abstract][Full Text] [Related]
4. Lack of clinical utility of serum macrophage migration inhibitory factor (MIF) for monitoring therapy response and estimating prognosis in advanced lung cancer.
Rupp A; Bahlmann S; Trimpop N; von Pawel J; Holdenrieder S
Tumour Biol; 2024; 46(s1):S341-S353. PubMed ID: 37545291
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of blood-based protein biomarkers in non-small cell lung cancer: A critical review and 2008-2022 update.
Trulson I; Holdenrieder S
Tumour Biol; 2024; 46(s1):S111-S161. PubMed ID: 37927288
[TBL] [Abstract][Full Text] [Related]
6. Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.
Wu L; Chen X; Peng T; Tang E; Bai W; Chen L
Int J Biol Markers; 2024 Jun; 39(2):141-148. PubMed ID: 38619974
[TBL] [Abstract][Full Text] [Related]
7. Circulating lung cancer biomarkers: From translational research to clinical practice.
Qian X; Meng QH
Tumour Biol; 2024; 46(s1):S27-S33. PubMed ID: 37927289
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract][Full Text] [Related]
9. Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel.
Izawa A; Hara Y; Horita N; Muraoka S; Kaneko M; Kaneko A; Somekawa K; Hirata M; Otsu Y; Matsumoto H; Nagasawa R; Tanaka K; Kubo S; Murohashi K; Aoki A; Fujii H; Watanabe K; Kobayashi N; Miura K; Nakajima H; Kaneko T
Transl Lung Cancer Res; 2024 Mar; 13(3):503-511. PubMed ID: 38601457
[TBL] [Abstract][Full Text] [Related]
10. Decline in serum progastrin-releasing peptide predicts the response of patients with small cell lung cancer to chemotherapy.
Li M; Han D; Wang W; Zhang Y; Li D; Dai C; Qian L; Lin W
Oncol Lett; 2020 Dec; 20(6):301. PubMed ID: 33101495
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of ProGRP for small cell lung cancer in different stages.
Dong A; Zhang J; Chen X; Ren X; Zhang X
J Thorac Dis; 2019 Apr; 11(4):1182-1189. PubMed ID: 31179060
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors.
Tutar N; Yetkin NA; Yazıcı C; Önal Ö; Kontaş O; Keleştemur F
Turk J Med Sci; 2019 Jun; 49(3):774-781. PubMed ID: 31091854
[TBL] [Abstract][Full Text] [Related]
13. Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with
Oya Y; Yoshida T; Uemura T; Murakami Y; Inaba Y; Hida T
Oncol Lett; 2018 Oct; 16(4):4219-4222. PubMed ID: 30214557
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
Ding C; Zhou X; Xu C; Chen J; Ju S; Chen T; Liang Z; Cui Z; Li C; Zhao J
Thorac Cancer; 2018 Nov; 9(11):1413-1420. PubMed ID: 30178907
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China.
Wu XY; Hu YB; Li HJ; Wan B; Zhang CX; Zhang B; Hu H; Zhang Q; Lv TF; Zhan P; Song Y
J Cell Mol Med; 2018 Sep; 22(9):4328-4334. PubMed ID: 29989303
[TBL] [Abstract][Full Text] [Related]
16. Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response.
Wojcik E; Kulpa JK
Lung Cancer (Auckl); 2017; 8():231-240. PubMed ID: 29238236
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and meta-analysis of the efficacy of serum neuron-specific enolase for early small cell lung cancer screening.
Huang L; Zhou JG; Yao WX; Tian X; Lv SP; Zhang TY; Jin SH; Bai YJ; Ma H
Oncotarget; 2017 Sep; 8(38):64358-64372. PubMed ID: 28969076
[TBL] [Abstract][Full Text] [Related]
18. Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer.
Lv ShP; Wang Y; Huang L; Wang F; Zhou JG; Ma H
Asian Pac J Cancer Prev; 2017 Feb; 18(2):391-397. PubMed ID: 28345820
[TBL] [Abstract][Full Text] [Related]
19. History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.
Nakamura H; Nishimura T
Surg Today; 2017 Sep; 47(9):1037-1059. PubMed ID: 28229299
[TBL] [Abstract][Full Text] [Related]
20. Instability of Plasma and Serum Progastrin-Releasing Peptide During Repeated Freezing and Thawing.
Lee JE; Lee JH; Hong M; Park SK; Yu JI; Shin SY; Kim SY
Osong Public Health Res Perspect; 2016 Dec; 7(6):351-355. PubMed ID: 28053839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
